Foundation News


Medicare B will cover an immunoglobulin therapy for patients with CIDP, starting July 18, 2021

A message from our industry partners at CSL Behring: We are pleased to share that effective July 18, Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, will be covered under Medicare Part B for maintenance therapy in adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).* Under the new coverage, Hizentra will be covered under the same benefit…

Read More about Medicare B will cover an immunoglobulin therapy for patients with CIDP, starting July 18, 2021

Live Webinar! CIDP: Improving Timely Diagnosis, Assessment, and Treatment (For Physicians Only)

Live Date: August 5, 2021 Time: 11:30am ET Program Expiration: August 5, 2022 While chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most common of the acquired immune-mediated demyelinating neuropathies, it remains a challenge to differentiate it from other immune-mediated inflammatory conditions. Clinicians may also find it difficult to recognize atypical presentations of CIDP. These issues…

Read More about Live Webinar! CIDP: Improving Timely Diagnosis, Assessment, and Treatment (For Physicians Only)

Live Webinar! Becoming Empowered with CIDP: Making My Voice Heard

We are pleased to announce a new, live video education session: “Becoming Empowered with CIDP: Making My Voice Heard” live on Thursday, August 5, 2021 at 10:00 AM ET.  An expert panel of neurology and pharmacy clinicians, as well as a patient with CIDP, will discuss the disease and review the questions every patient should…

Read More about Live Webinar! Becoming Empowered with CIDP: Making My Voice Heard

Angela’s Adaptive Devices

Written by Angela Patton Angela Patton is a member of GBS|CIDP’s Advisory Committee. In 2017, after an eight months struggle for a proper diagnosis, Angela was diagnosed with CIDP.  Here is Angela’s story… I was barely able to walk, and struggled during this time in my educational, and professional life. I have been on various…

Read More about Angela’s Adaptive Devices